Jaffe Book Solutions Inspires Creativity with the Help of Canon Solutions America
Jun 07, 2016 12:37 pm UTC| Business
MELVILLE, N.Y., June 7, 2016 -- Canon Solutions America, Inc., a wholly owned subsidiary of Canon U.S.A., Inc., today announced that its longtime customer, Jaffe Book Solutions (JBS), has installed the Canon imagePRESS...
Jun 07, 2016 12:13 pm UTC| Business
AM-101 has potential to be first-ever approved therapy for tinnitus Top-line results from first of two Phase 3 trials expected in August ZUG, Switzerland, June 7, 2016 -- Auris Medical Holding AG (NASDAQ: EARS), a...
CPR Ready Campaign aims to save lives through CPR Preparedness
Jun 07, 2016 11:01 am UTC| Business
PHILADELPHIA, June 7, 2016 -- The Philadelphia Regional CPR Awareness Coalition ("the Coalition") today launched CPR Ready, a campaign designed to increase the number of people in the region who are qualified and willing...

Safety – or profit? The booming business of CCTV and Safer Streets
Jun 07, 2016 09:24 am UTC| Insights & Views Business
Closed circuit street cameras have been sold to the community as a way of making us safer, reducing crime and discouraging anti-social behaviour. But research into the Federal Governments $50 million Safer Streets program...
Stolt-Nielsen Limited: Contemplates Issuance of Bonds
Jun 07, 2016 09:06 am UTC| Business
LONDON, June 7, 2016 -- Stolt-Nielsen Limited (Oslo Brs: SNI) is contemplating the issuance of new senior unsecured bonds in the Norwegian bond market through increases of one or more of the company's existing bond...
ADVA Optical Networking Wins Celtic-Plus Award for Key Role in SASER Project
Jun 07, 2016 07:31 am UTC| Business
STOCKHOLM, Sweden, June 7, 2016 -- ADVA Optical Networking announced today that it has been named the winner of the 2016 Celtic-Plus Excellence Award in the Category of Network Technologies, alongside the other...
Targovax ASA: Patient recruitment for TG01 immuno-oncology trial completed
Jun 07, 2016 06:21 am UTC| Business
OSLO, Norway, June 7, 2016 -- Targovax announces today that the open label Phase I/ II clinical trial of TG01 in combination with gemcitabine of patients with resected pancreatic cancer is fully recruited. A total of 32...